Financials
- Market Capitalization 26.15 M
- Employee 66
- Founded 2010
- CEO Eric Shaff
- Website www.serestherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG0099X6859
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
23.25
売上高対価格比率
167.28
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4383 | IGC IGC Pharma, Inc. Common Stock | 0.28 USD | 0.00% | 0.00% | 0.00% | +9.29% | 28.95 M USD | ||
| 4394 | CNTX Context Therapeutics Inc. - Common Stock | 0.30 USD | -3.23% | -3.23% | -18.92% | -79.59% | 27.56 M USD | ||
| 4406 | ABVC ABVC BioPharma, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +6.52% | -69.94% | 26.12 M USD | ||
| 4408 | ATYR aTyr Pharma, Inc. - Common Stock | 0.26 USD | -7.14% | -10.34% | -44.68% | -73.20% | 25.50 M USD |